PURPOSE We evaluated the accuracy of detrusor wall thickness and intravesical prostatic protrusion, and the association of each test to diagnose bladder prostatic obstruction in patients with lower urinary tract symptoms. MATERIALS AND METHODS We enrolled in the study 100 consecutive patients with lower urinary tract symptoms due to benign prostatic hyperplasia. Baseline parameters were Inter...

OBJECTIVE  To estimate the risk of erectile dysfunction in men who used 5-α reductase inhibitors to treat benign prostatic hyperplasia or alopecia. DESIGN  Cohort studies with nested case-control analyses. SETTING  UK Clinical Practice Research Datalink. POPULATION  Two populations of men free of risk factors for erectile dysfunction and other sexual dysfunction or its treatment: men aged...

Purpose To evaluate the efficacy and safety of a minimally invasive treatment for benign prostatic hyperplasia (BPH) by transurethral dehydrated ethanol injection. Patients and method Eight patients with clinical symptoms of benign prostatic hyperplasia were evaluated by urodynamic study, cystoscope and transrectal ultrasound preoperatively. Under regional anesthesia, transurethral injection wa...

Estrogen has important roles in the initiation and development of benign prostatic hyperplasia (BPH). Regulators of the estrogen receptor (ER) are tissue- and cell-specific. We evaluated the effect of estrogen antagonist, raloxifene (Ral), on the prevention and treatment of BPH by investigating its effect on the proliferation of two different prostate cell lines: a stromal cell line, WPMY-1, an...